Related references
Note: Only part of the references are listed.Two-year clinical outcomes of zotarolimus- and everolimus-eluting durable-polymer-coated stents versus biolimus-eluting biodegradable-polymer-coated stent in patients with acute myocardial infarction with dyslipidemia after percutaneous coronary intervention: data from the KAMIR
Yong Hoon Kim et al.
HEART AND VESSELS (2019)
One-year clinical outcomes between biodegradable-polymer-coated biolimus-eluting stent and durable-polymer-coated drug-eluting stents in STEMI patients with multivessel coronary artery disease undergoing culprit-only or multivessel PCI
Yong Hoon Kim et al.
ATHEROSCLEROSIS (2019)
Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI
Yong Hoon Kim et al.
ATHEROSCLEROSIS (2019)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Borja Ibanez et al.
EUROPEAN HEART JOURNAL (2018)
One-Year Outcomes after PCI Strategies in Cardiogenic Shock
H. Thiele et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: A pooled patient-level meta-analysis of randomized trials
Giuseppe De Luca et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes
Manesh R. Patel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Survival After Varying Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease A Pairwise and Network Meta-Analysis
Giuseppe Tarantini et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2016)
Comparison of 4.5-Year Outcomes of Bare-Metal and Zotarolimus-Eluting Stents in New York
Feng Qian et al.
JOURNAL OF INTERVENTIONAL CARDIOLOGY (2016)
Is There Any Significant Difference in Stent Thrombosis Between Sirolimus and Paclitaxel Eluting Stents? A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Pravesh Kumar Bundhun et al.
MEDICINE (2016)
Long-term follow-up of second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction: three-year results of the XAMI trial
Sjoerd H. Hofma et al.
EUROINTERVENTION (2015)
Two-Year Outcomes After First- or Second-Generation Drug-Eluting or Bare-Metal Stent Implantation in All-Comer Patients Undergoing Percutaneous Coronary Intervention
Marco Valgimigli et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2014)
Impact of Advanced Age on the Safety and Effectiveness of Paclitaxel-Eluting Stent Implantation in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty: The HORIZONS-AMI Trial
Dariusz Dudek et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2013)
Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial
Pieter Cornelis Smits et al.
LANCET (2013)
Drug-Eluting vs Bare-Metal Stents in Primary Angioplasty
Giuseppe De Luca et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents A Mixed-Treatment Comparison Analysis of 117 762 Patient-Years of Follow-Up From Randomized Trials
Sripal Bangalore et al.
CIRCULATION (2012)
Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial
Manel Sabate et al.
LANCET (2012)
Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: The HORIZONS-AMI trial
Damian J. Kelly et al.
AMERICAN HEART JOURNAL (2011)
Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings
Kumaran Kolandaivelu et al.
CIRCULATION (2011)
Culprit-Lesion-Only Versus Multivessel Revascularization Using Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: A Korean Acute Myocardial Infarction Registry-Based Analysis
Hyun Su Jo et al.
KOREAN CIRCULATION JOURNAL (2011)
Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: A meta-analysis of randomized trials
Giuseppe De Luca et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Outcomes associated with drug-eluting and bare-metal stents:: a collaborative network meta-analysis
Christoph Stettler et al.
LANCET (2007)
Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction
Paul Sorajja et al.
EUROPEAN HEART JOURNAL (2007)
Short- and long-term clinical benefit of sirolimus-eluting Stents compared to conventional bare stents for patients with acute myocardial infarction
PA Lemos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Multiple complex coronary plaques in patients with acute myocardial infarction.
JA Goldstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
